The interaction of nitric oxide and superoxide in the human fetal-placental vasculature

Am J Obstet Gynecol. 1995 Aug;173(2):528-33. doi: 10.1016/0002-9378(95)90278-3.

Abstract

Objective: Our purpose was to study the interaction of nitric oxide and superoxide anion on the vasculature of the isolated perfused human placental cotyledon.

Study design: Isolated placental cotyledons were preconstricted with the thromboxane mimetic U46619, and fetal perfusion pressure was used as an index of response. The interaction of nitric oxide and O2- was studied by three protocols: (1) with endogenous nitric oxide, (2) with addition of exogenous nitric oxide, and (3) with inhibition of nitric oxide synthesis by the nitric oxide synthase inhibitor N-nitro-L-arginine. O2- was generated by infusion of purine-xanthine oxidase. Statistical significance of response to treatment was determined by paired t test.

Results: Infusion of xanthine oxidase with purine in the presence of endogenous nitric oxide resulted in vasodilation (p < 0.05). Vasodilation was more pronounced in the presence of exogenous nitric oxide (p < 0.008). Coinfusion of xanthine oxidase with purine in the presence of N-nitro-L-arginine to inhibit nitric oxide synthesis resulted in vasoconstriction.

Conclusion: We conclude that, rather than superoxide inactivating nitric oxide, interaction of the two radicals generates in the placental vasculature a vasodilator, which may be peroxynitrite.

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Amino Acid Oxidoreductases / antagonists & inhibitors
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Fetus / blood supply*
  • Humans
  • In Vitro Techniques
  • Nitric Oxide / pharmacology*
  • Nitric Oxide Synthase
  • Nitroarginine
  • Placenta / blood supply*
  • Prostaglandin Endoperoxides, Synthetic / pharmacology
  • Purines / pharmacology
  • Superoxides / pharmacology*
  • Thromboxane A2 / analogs & derivatives
  • Thromboxane A2 / pharmacology
  • Vasoconstriction / drug effects
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects
  • Xanthine Oxidase / pharmacology

Substances

  • Prostaglandin Endoperoxides, Synthetic
  • Purines
  • Vasoconstrictor Agents
  • Superoxides
  • Nitroarginine
  • Nitric Oxide
  • Thromboxane A2
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Arginine
  • Nitric Oxide Synthase
  • Xanthine Oxidase
  • Amino Acid Oxidoreductases
  • purine